Brief description. The “Health System Strengthening” (HSS) Project is to undertake the construction (1 Medical Warehouse, 5 TB-MDR Wards and 17 shelters for TB clinics) and rehabilitation works, as part of the grant agreements between the Ministry of Health of the Republic of Mozambique (MoH) with the Global Fund to fight AIDS, Tuberculosis (TB) and Malaria (GF), in Mozambique in the area of HIV and TB (MOZ-H-MOH, MOZ-T-MOH). Within this project UNDP supports the Ministry of Health of the Republic of Mozambique, through the Central Medical Store of Mozambique (CMAM) to strengthen the capacities of the national medicine supply system and the National Tuberculosis Control Programme (NTP), to provide quality health services to the population of Mozambique at national and local level, living in remote areas, in absolute poverty, which includes people living with HIV and AIDS, Multi-drug Resistant Tuberculosis (MDR-TB) patients. UNDP intervention under this Project contributes to the implementation of the CMAM Strategic Plan for Pharmaceutical Logistics (PELF) in two phases. In phase I, UNDP supports the reconstruction of Manica warehouse, five MDR-TB wards and seventeen waiting areas for the TB patients. In Phase II, UNDP will manage the rehabilitation of provincial warehouses, including the Beira Regional warehouse. UNDP support contributes to the CMAM and NTP efforts to improve treatment outcome of MDR-TB, infectious disease control, and storage conditions of the medicines, vaccines and other health products. Objective: The main objective of the HSS Project is to strengthen the national health system by reinforcing the medical supply chain system management and enhancing the MDR-TB treatment outcome through: • Improved safety, security and storage conditions of medicines, vaccines and other health products at sub-national level through the construction of a provincial warehouse in Chimoio (Phase I), the rehabilitation of provincial warehouses and repairs in Beira Regional warehouse (Phase II); • Improved conditions of clinical care for MDR TB patients through the construction of five new wards for multi-drug resistant patients and 17 waiting shelters in the TB clinics (Phase I). Coverage/locations: National coverage, with prioritized provinces for: • Construction of medical warehouse: Manica
Brief description. The Severe Insulin Resistance (SIR) sample set will form part of the “rare disease” group, and will undergo exome sequencing. Conditions: No constraints. Data can be used as controls: Yes.
Brief description. The samples for genetic neuromuscular diseases will be part of the “rare disease” group, and will undergo exome sequencing. They fall into the following groups:
Examples of Brief description in a sentence
Brief description, including any part or model numbers of each contract item or component on which the royalty is payable.
Brief description of litigation history (disputes, arbitration, claims, etc.), indicating current status and outcomes, if already resolved.12.
In case a question / issue does not apply to a tenderer, the same should be answered with the remark "not applicable".Wherever necessary and applicable, the tenderer shall enclose certified copy as documentary proof / evidence to substantiate the corresponding statement.In case a tenderer furnishes a wrong or evasive answer against any of the under mentioned question/ issues, its tender will be liable to be ignored.1. Brief description and of goods and services offered:2.
Brief description of litigation history (disputes, arbitration, claims, etc.), indicating current status and outcomes, if already resolved.13.
Brief description of litigation history (disputes, arbitration, claims, etc.), indicating current status and outcomes, if already resolved.
More Definitions of Brief description
Brief description. The ciliopathies are an emerging group of disorders that arise from some dysfunction of cilia both motile or immotile forms. It is predicted that over 100 known conditions are likely to fall under this category, but only a handful have thus far been studied in any depth. Most individual ciliopathies are rare with just a small number of cases having been reported, thereby presenting researchers with often insurmountable difficulties for causative gene identification.
Brief description. The MGAS (Molecular Genetics of Autism Study) samples are from a clinical sample seen by specialists at the Maudsley hospital and who have had detailed phenotypic assessments with ADI-R and ADOS. Conditions: The data can only be used to identify genes for Autism Spectrum Disorders. The data must be kept confidentially and securely. Data can be used as controls: No.
Brief description. Debit Card Types of Transactions: debit card means a general purpose payment card or any other device, technology, medium or form factor that accesses an asset Account, such as a demand deposit account or savings account for use in offline (e.g., signature-based) and/or online (e.g. PIN- based) purchase transactions or cash withdrawals. You may use the debit card and personal identification number (PIN) issued to you to pay for purchases from merchants who have agreed to accept the debit card at point of sale terminals within the networks identified on your debit card and such other terminals as the Bank may designate from time to time. We reserve the right to block transactions with certain merchants that otherwise accept VISA debit cards. You may NOT use your debit card for illegal activity. Our processor can block transactions for illegal or potentially fraudulent uses such as Internet gambling.
Brief description. The TwinsUK samples will be part of the cohort study and will undergo whole genome sequencing. Conditions: No additional constraints. Data can be used as controls: Yes. Acknowledgement: The TwinsUK Cohort UK10K_COHORT_ALSPAC EGA Study ID: EGAS00001000090. Please refer to the EGA for this study’s Dataset IDs.
Brief description. This sample set consists of subjects with schizophrenia recruited from psychiatric in-patient and out-patient facilities in Scotland. All diagnoses are based on standard research procedures and family histories are available. Patients have IQ>70 and the cohort includes the following groups: 100 cases with detailed clinical, cognitive and structural and functional neuroimaging phenotypes; 138 familial cases who are the probands of families where DNA has been collected from other affected members; 162 unrelated individuals. In most cases patients and their families may be re contacted to take part in further studies. Conditions: There are no additional constraints on the analyses that can be carried out Data can be used as controls: Yes.
Brief description. The Tampere Autism sample set consists of samples from Finnish subjects with ASD (autism spectrum disorders) with IQs over 70 recruited from a clinical centre for the diagnosis and treatment of children with ASD.
Brief description. This sample set comprises cases of schizophrenia with additional cognitive measurements, collected in Aberdeen, Scotland. Conditions: No additional constraints, if anonymised. Data can be used as controls: Yes, if anonymised. Acknowledgement: Scottish schizophrenia cases. UK10K_NEURO_ASD_GALLAGHER EGA Study ID: EGAS00001000112. Please refer to the EGA for this study’s Dataset IDs. Brief description: This is an Irish sample set of individuals with ASD (approximately 50% with comorbid intellectual disability). Individuals have been diagnosed with ADI/ ADOS, measures of cognition/ adaptive function. They represent a more severe, narrowly defined cohort of ASD subjects. Family histories are available for some with measures of broader phenotype. Conditions: No additional constraints. Data can be used as controls: Yes. Acknowledgement: Trinity College Dublin Autism Genetics Collection. UK10K_NEURO_GURLING EGA Study ID: EGAS00001000225. Please refer to the EGA for this study’s Dataset IDs.